SLC33A1
Basic information
Region (hg38): 3:155821024-155854456
Previous symbols: [ "ACATN", "SPG42" ]
Links
Phenotypes
GenCC
Source:
- hereditary spastic paraplegia 42 (Supportive), mode of inheritance: AD
- Huppke-Brendel syndrome (Supportive), mode of inheritance: AR
- Huppke-Brendel syndrome (Strong), mode of inheritance: AR
- hereditary spastic paraplegia 42 (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Huppke-Brendel syndrome | AR | Audiologic/Otolaryngologic; Biochemical | Medical treatment (with copper supplementation) has been reported as biochemically and clinically beneficial in some individuals; Awareness of the potential of hearing loss may allow early identification and interventions to support speech and language development | Audiologic/Otolaryngologic; Biochemical; Neurologic; Ophthalmologic | 15902551; 19061983; 20461110; 22243965; 22508683 |
ClinVar
This is a list of variants' phenotypes submitted to
- Huppke-Brendel syndrome (1 variants)
- Spastic paraplegia (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC33A1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 47 | 57 | ||||
missense | 107 | 112 | ||||
nonsense | 2 | |||||
start loss | 1 | |||||
frameshift | 2 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 4 | 4 | ||||
non coding | 14 | 14 | 30 | |||
Total | 1 | 0 | 124 | 65 | 16 |
Variants in SLC33A1
This is a list of pathogenic ClinVar variants found in the SLC33A1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-155826533-GTTTT-G | Spastic paraplegia, autosomal dominant | Likely benign (Jun 14, 2016) | ||
3-155827316-TA-T | Spastic paraplegia, autosomal dominant | Uncertain significance (Jun 14, 2016) | ||
3-155827626-CTT-C | Spastic paraplegia, autosomal dominant | Uncertain significance (Jun 14, 2016) | ||
3-155828030-C-CA | Benign (Aug 15, 2019) | |||
3-155828040-AT-A | Benign (Jul 31, 2018) | |||
3-155828214-T-C | Spastic paraplegia | Uncertain significance (Jul 07, 2022) | ||
3-155828218-T-C | Spastic paraplegia | Uncertain significance (Sep 29, 2022) | ||
3-155828234-C-G | Hereditary spastic paraplegia | Uncertain significance (Nov 01, 2018) | ||
3-155828235-G-A | Uncertain significance (Dec 17, 2019) | |||
3-155828245-C-A | Spastic paraplegia | Uncertain significance (May 27, 2022) | ||
3-155828258-C-T | Spastic paraplegia | Likely benign (Sep 18, 2023) | ||
3-155828261-T-C | Spastic paraplegia | Likely benign (May 09, 2023) | ||
3-155828264-A-G | Spastic paraplegia | Likely benign (Jun 05, 2021) | ||
3-155828273-A-T | Spastic paraplegia | Likely benign (Nov 14, 2023) | ||
3-155828281-A-C | Spastic paraplegia | Conflicting classifications of pathogenicity (Oct 03, 2023) | ||
3-155828291-A-G | Spastic paraplegia • Hereditary spastic paraplegia | Benign/Likely benign (Jul 17, 2023) | ||
3-155828300-A-G | Spastic paraplegia | Likely benign (Feb 23, 2024) | ||
3-155828301-A-C | Spastic paraplegia | Uncertain significance (Sep 27, 2022) | ||
3-155828301-A-G | Spastic paraplegia • Hereditary spastic paraplegia • Hereditary spastic paraplegia 42 | Uncertain significance (Aug 17, 2023) | ||
3-155828324-C-T | Hereditary spastic paraplegia | Uncertain significance (Apr 01, 2019) | ||
3-155828325-A-G | Spastic paraplegia | Uncertain significance (Jan 04, 2021) | ||
3-155828329-A-G | Uncertain significance (Mar 27, 2023) | |||
3-155828330-A-G | Spastic paraplegia | Likely benign (Jul 06, 2022) | ||
3-155828335-C-T | Spastic paraplegia • Hereditary spastic paraplegia 42 • not specified • Hereditary spastic paraplegia | Conflicting classifications of pathogenicity (Jan 26, 2025) | ||
3-155828338-CCAGGGCTGTAA-C | Spastic paraplegia • Hereditary spastic paraplegia 42 • Hereditary spastic paraplegia | Uncertain significance (Feb 04, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC33A1 | protein_coding | protein_coding | ENST00000392845 | 6 | 33406 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000989 | 0.988 | 125730 | 0 | 18 | 125748 | 0.0000716 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.98 | 193 | 287 | 0.672 | 0.0000131 | 3543 |
Missense in Polyphen | 37 | 78.652 | 0.47043 | 993 | ||
Synonymous | -0.350 | 118 | 113 | 1.04 | 0.00000550 | 1127 |
Loss of Function | 2.23 | 10 | 21.0 | 0.476 | 9.56e-7 | 271 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000905 | 0.0000904 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000973 | 0.0000967 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Probable acetyl-CoA transporter necessary for O- acetylation of gangliosides (PubMed:9096318). Negatively regulates BMP signaling (PubMed:25402622). {ECO:0000269|PubMed:25402622, ECO:0000269|PubMed:9096318}.;
- Disease
- DISEASE: Congenital cataracts, hearing loss, and neurodegeneration (CCHLND) [MIM:614482]: An autosomal recessive disorder characterized by congenital cataracts, severe psychomotor retardation, and hearing loss associated with decreased serum ceruloplasmin and copper. Brain MRI shows cerebral and cerebellar atrophy and hypomyelination. {ECO:0000269|PubMed:22243965}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Glycosphingolipid biosynthesis - ganglio series - Homo sapiens (human);Ganglio Sphingolipid Metabolism;3-oxo-10R-octadecatrienoate beta-oxidation;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of small molecules
(Consensus)
Intolerance Scores
- loftool
- 0.662
- rvis_EVS
- 0.2
- rvis_percentile_EVS
- 67.19
Haploinsufficiency Scores
- pHI
- 0.672
- hipred
- Y
- hipred_score
- 0.566
- ghis
- 0.541
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.223
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc33a1
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); embryo phenotype; renal/urinary system phenotype; immune system phenotype; vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); neoplasm; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- slc33a1
- Affected structure
- motor neuron
- Phenotype tag
- abnormal
- Phenotype quality
- increased branchiness
Gene ontology
- Biological process
- acetyl-CoA transport;BMP signaling pathway;transmembrane transport;SMAD protein signal transduction;proton transmembrane transport
- Cellular component
- Golgi membrane;endoplasmic reticulum membrane;integral component of plasma membrane;membrane
- Molecular function
- acetyl-CoA transmembrane transporter activity;solute:proton symporter activity